Current dosing of growth hormone in children with growth hormone deficiency: How physiologic?

Pediatrics

Volumn 102, Issue 2 III, 1998, Pages 527-530

  MacGillivray, Margaret H ^a,c   Blethen, Sandra L ^b   Buchlis, John G ^a   Clopper, Richard R ^a   Sandberg, David E ^a   Conboy, Thomas A ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b GENENTECH INC   (United States)

^c CHILDREN S HOSPITAL OF BUFFALO   (United States)

Author keywords

Bone age; Growth hormone dose; Height outcomes; Onset of puberty

Indexed keywords

RECOMBINANT GROWTH HORMONE;

ADOLESCENT; BODY HEIGHT; BONE AGE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PUBERTY; RADIOIMMUNOASSAY; REVIEW; SCHOOL CHILD; SCORING SYSTEM;

BODY HEIGHT; CHILD; FEMALE; GROWTH; GROWTH HORMONE; HUMANS; MALE; PUBERTY;

EID: 0031879293     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. MacGillivray MH, Blizzard RM. Rationale for dosing recombinant human growth hormone by weight rather than units. Growth Genet Horm. 1994;10:7-9
2. MacGillivray MH, Frohman LA, Doe J. Metabolic clearance and production rates of human growth hormone in subjects with normal and abnormal growth. J Clin Endocrinol Metab. 1970;30:632-638
3. Finkelstein JW, Roffwarg HP, Boyar RM, et al. Age-related change in the twenty-four hour spontaneous secretion of growth hormone. J Clin Endocrinol Metab. 1972;35:665-670
4. Kowarski A, Thompson RG, Migeon CJ, et al. Determination of integrated plasma concentrations and true secretion rates of human growth hormone. J Clin Endocrinol Metab. 1971;32:356-360
5. Plotnick LP, Thompson RG, Kowarski A, et al. Circadian variation of integrated concentration of growth hormone in children and adults. J Clin Endocrinol Metab. 1972;40:240-247
6. Martha PM Jr, Gorman KM, Blizzard RM, et al. Endogenous growth hormone secretion and clearance rates in normal boys as determined by deconvolution analysis: analyses to age, pubertal status, and body mass. J Clin Endocrinol Metab. 1992;74:336-344
7. Rosenbaum M, Gertner JM. Metabolic clearance rates of synthetic human growth hormone in children, adult women, and adult men. J Clin Endocrinol Metab. 1989;69:821-824
8. Kemp SF. Growth hormone therapeutic practice dosing issues. Endocrinologist. 1996;6:231-237
9. Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab. 1991;73:1081-1088
10. Frasier SD, Costin G, Lippe BM, et al. A dose-response curve for human growth hormone. J Clin Endocrinol Metab. 1981;53:1213-1217
11. The American Norditropin Trial Group. Cohen P, Rosenfeld RG, eds. Dose response effects of growth hormone on auxological and biochemical parameters in GH deficient children. In press
12. MacGillivray MH, Clopper RR, Sandberg DE, et al. Growth responses of hypopituitary children to growth hormone (GH) treatment during the pituitary (pGH) and recombinant (rGH) eras. Horm Res. 1997;48(suppl 2):85
13. Blethen SL, Baptista J, Kuntze J, et al. Adult height in growth hormone (GH) deficient children treated with biosynthetic GH. J Clin Endocrinol Metab. 1997;82:418-420
14. Ranke MB, Price DA, Albertsson-Wikland K, et al. Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency. Horm Res. 1997;48:62-71
15. August GP, Julius JR, Blethen SL. Adult height in children with growth hormone deficiency who are treated with biosynthetic growth hormone: the National Cooperative Growth Study experience. Pediatrics. 1998;102: 512-516
16. Burns EC, Tanner JM, Preece MA, et al. Height and pubertal development in 55 children with idiopathic growth hormone deficiency treated for between 2 and 15 years with human growth hormone. Eur J Pediatr. 1981;137:155-163
17. Dean HJ, McTaggart TL, Fish DG, et al. The educational, vocational, and marital status of growth hormone-deficient adults treated with growth hormone during childhood. Am J Dis Child. 1985;139:1105-1110
18. Clopper RR, MacGillivray MH, Mazur T, et al. Post-treatment follow-up of growth hormone deficient patients: psychosocial status. In: Stabler B, Underwood LE, eds. Slow Grows the Child: Psychosocial Aspects of Growth Delay. New York, NY: Lawrence Erlbaum Associates; 1986:83-96
19. Mitchell CM, Johanson AJ, Joyce S, et al. Psychosocial impact of long-term growth hormone therapy. In: Stabler B, Underwood LE, eds. Slow Grows the Child: Psychosocial Aspects of Growth Delay. New York, NY: Lawrence Erlbaum Associates: 1986:97-109
20. Dean HJ, McTaggart TL, Fish DG, et al. Long-term social follow-up of growth hormone deficient adults treated with growth hormone during childhood. In: Stabler B, Underwood LE, eds. Slow Grows the Child: Psychosocial Aspects of Growth Delay. New York, NY: Lawrence Erlbaum Associates; 1986:73-82
21. Libber SM, Plotnick LP, Johanson AJ, et al. Long-term follow-up of hypopituitary patients treated with human growth hormone. Medicine. 1990;69:46-55
22. Wit JM, Kamp GA, Rikken B, et al. Spontaneous growth and response to growth hormone in children with growth hormone deficiency and idiopathic short stature. Pediatr Res. 1996;39:295-302
23. MacGillivray MH, Baptista J, Johanson A. Outcome of a four-year randomized study of daily versus three times weekly somatropin treatment in prepubertal naive growth hormone deficient children. J Clin Endocrinol Metab. 1996;81:1806-1809
24. Stanhope R, Albanese A, Hindmarsh P, et al. The effects of growth hormone therapy on spontaneous sexual development. Horm Res. 1992; 39:9-13
25. Blethen SL, Allen DB, Graves D, et al. Safety of recombinant deoxyribonucleic acid-derived growth hormone: the National Cooperative Growth Study experience. J Clin Endocrinol Metab. 1996;81:1704-1710
26. Allen DB, Rundle AC, Graves DA, et al. Risk of leukemia in children treated with human growth hormone: review and reanalyses. J Pediatr. 1997;131:S32-S37
27. Attie KM, Julius JR, Stoppani C, et al. National Cooperative Growth Study Substudy. VI. The clinical utility of growth-hormone-binding protein, insulin-like growth factor-binding protein 3 measurements. J Pediatr. 1997;131:S56-S60
28. Baens-Bailon R, Foley T, Hintz RL, et al. Excessive growth hormone dosing in GH deficiency. Pediatr Res. 1992;31:73A
29. Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Furlanetto RW, ed. Guidelines for the use of growth hormone in children with short stature. J Pediatr. 1995;127:857-867